West Pharmaceutical Services Inc banner

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 242.33 USD -0.83%
Market Cap: $17.4B

Income Statement

Earnings Waterfall
West Pharmaceutical Services Inc

Income Statement
West Pharmaceutical Services Inc

Rotate your device to view
Income Statement
Currency: USD
Mar-2002 Jun-2002 Sep-2002 Dec-2002 Mar-2003 Jun-2003 Sep-2003 Dec-2003 Mar-2004 Jun-2004 Sep-2004 Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Jun-2006 Sep-2006 Dec-2006 Mar-2007 Jun-2007 Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Revenue
Interest Expense
0
0
0
11
0
0
0
10
0
0
0
9
2
6
10
14
15
16
0
13
6
7
11
15
16
16
16
16
16
15
15
15
15
16
16
17
18
18
19
18
18
18
18
17
17
17
17
17
16
17
17
17
17
16
15
14
13
11
10
8
8
8
6
7
7
7
8
8
9
8
8
8
8
8
8
8
8
8
8
8
9
8
9
8
8
9
10
9
8
7
5
3
2
0
(0)
1
Revenue
395
N/A
401
+2%
408
+2%
413
+1%
436
+6%
456
+5%
467
+2%
483
+4%
496
+3%
506
+2%
523
+4%
542
+3%
561
+4%
598
+7%
646
+8%
700
+8%
773
+10%
840
+9%
877
+4%
913
+4%
948
+4%
972
+2%
996
+3%
1 020
+2%
1 033
+1%
1 049
+2%
1 062
+1%
1 051
-1%
1 023
-3%
1 004
-2%
1 007
+0%
1 056
+5%
1 088
+3%
1 109
+2%
1 121
+1%
1 105
-1%
1 125
+2%
1 152
+2%
1 174
+2%
1 192
+2%
1 213
+2%
1 230
+1%
1 240
+1%
1 266
+2%
1 290
+2%
1 309
+2%
1 347
+3%
1 368
+2%
1 376
+1%
1 400
+2%
1 414
+1%
1 421
+1%
1 411
-1%
1 401
-1%
1 390
-1%
1 400
+1%
1 426
+2%
1 454
+2%
1 487
+2%
1 509
+2%
1 535
+2%
1 544
+1%
1 566
+1%
1 599
+2%
1 627
+2%
1 677
+3%
1 711
+2%
1 717
+0%
1 745
+2%
1 767
+1%
1 792
+1%
1 840
+3%
1 888
+3%
1 945
+3%
2 037
+5%
2 147
+5%
2 326
+8%
2 523
+8%
2 681
+6%
2 832
+6%
2 881
+2%
2 929
+2%
2 909
-1%
2 887
-1%
2 884
0%
2 866
-1%
2 927
+2%
2 950
+1%
2 929
-1%
2 877
-2%
2 876
0%
2 893
+1%
2 896
+0%
2 960
+2%
3 018
+2%
3 074
+2%
Gross Profit
Cost of Revenue
(279)
(284)
(291)
(295)
(313)
(322)
(324)
(330)
(340)
(348)
(365)
(385)
(398)
(427)
(467)
(503)
(558)
(605)
(626)
(649)
(671)
(689)
(708)
(738)
(738)
(747)
(759)
(749)
(734)
(721)
(718)
(752)
(772)
(788)
(797)
(787)
(802)
(826)
(842)
(853)
(861)
(864)
(865)
(879)
(891)
(899)
(922)
(934)
(946)
(960)
(970)
(974)
(959)
(954)
(944)
(944)
(957)
(970)
(989)
(1 008)
(1 023)
(1 041)
(1 058)
(1 087)
(1 114)
(1 147)
(1 170)
(1 172)
(1 187)
(1 194)
(1 206)
(1 234)
(1 262)
(1 282)
(1 327)
(1 379)
(1 453)
(1 530)
(1 595)
(1 654)
(1 691)
(1 732)
(1 732)
(1 751)
(1 761)
(1 773)
(1 813)
(1 821)
(1 841)
(1 850)
(1 873)
(1 895)
(1 896)
(1 916)
(1 944)
(1 970)
Gross Profit
116
N/A
117
+1%
117
0%
118
+1%
123
+5%
134
+9%
143
+7%
153
+7%
157
+2%
158
+1%
158
+0%
157
-1%
163
+4%
171
+5%
179
+5%
197
+10%
215
+9%
236
+10%
251
+7%
265
+5%
278
+5%
283
+2%
288
+2%
282
-2%
295
+5%
302
+2%
303
+1%
303
0%
288
-5%
284
-2%
289
+2%
304
+5%
317
+4%
321
+1%
324
+1%
318
-2%
324
+2%
325
+0%
332
+2%
339
+2%
352
+4%
367
+4%
376
+2%
388
+3%
398
+3%
411
+3%
426
+4%
435
+2%
429
-1%
440
+3%
445
+1%
448
+1%
451
+1%
448
-1%
446
0%
456
+2%
469
+3%
485
+3%
497
+3%
501
+1%
512
+2%
504
-2%
508
+1%
513
+1%
513
+0%
530
+3%
541
+2%
545
+1%
558
+2%
574
+3%
586
+2%
606
+3%
626
+3%
663
+6%
710
+7%
768
+8%
873
+14%
993
+14%
1 086
+9%
1 178
+8%
1 190
+1%
1 197
+1%
1 177
-2%
1 136
-3%
1 123
-1%
1 093
-3%
1 113
+2%
1 129
+1%
1 088
-4%
1 027
-6%
1 003
-2%
999
0%
1 000
+0%
1 044
+4%
1 074
+3%
1 104
+3%
Operating Income
Operating Expenses
(72)
(75)
(76)
(68)
(87)
(93)
(89)
(91)
(93)
(93)
(103)
(105)
(107)
(112)
(117)
(123)
(135)
(141)
(151)
(159)
(165)
(169)
(170)
(169)
(174)
(178)
(182)
(177)
(180)
(184)
(183)
(197)
(200)
(202)
(207)
(210)
(215)
(217)
(220)
(220)
(222)
(228)
(237)
(246)
(254)
(264)
(268)
(273)
(271)
(269)
(270)
(267)
(263)
(275)
(318)
(327)
(333)
(328)
(283)
(275)
(280)
(278)
(272)
(273)
(278)
(286)
(297)
(295)
(293)
(289)
(294)
(308)
(312)
(323)
(334)
(350)
(363)
(381)
(398)
(421)
(421)
(412)
(390)
(381)
(390)
(399)
(422)
(424)
(427)
(423)
(417)
(409)
(414)
(428)
(449)
(473)
Selling, General & Administrative
(74)
(78)
(78)
(68)
(87)
(92)
(88)
(91)
(92)
(91)
(102)
(105)
(105)
(111)
(116)
(115)
(131)
(134)
(139)
(148)
(149)
(152)
(155)
(153)
(156)
(158)
(162)
(159)
(162)
(166)
(169)
(178)
(181)
(182)
(183)
(188)
(192)
(192)
(193)
(191)
(192)
(200)
(208)
(218)
(226)
(231)
(234)
(235)
(232)
(230)
(230)
(229)
(228)
(242)
(240)
(244)
(247)
(238)
(241)
(240)
(243)
(241)
(245)
(243)
(249)
(259)
(262)
(263)
(263)
(264)
(263)
(273)
(276)
(283)
(295)
(302)
(310)
(325)
(341)
(362)
(365)
(354)
(328)
(317)
(320)
(326)
(349)
(353)
(354)
(349)
(343)
(334)
(338)
(350)
(368)
(389)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(8)
(3)
(5)
(8)
(11)
(12)
(13)
(15)
(16)
(18)
(19)
(19)
(19)
(18)
(18)
(18)
(20)
(21)
(22)
(23)
(24)
(25)
(27)
(29)
(29)
(31)
(31)
(32)
(33)
(34)
(35)
(37)
(38)
(39)
(39)
(39)
(37)
(35)
(33)
(32)
(34)
(36)
(37)
(37)
(37)
(38)
(39)
(39)
(39)
(38)
(39)
(40)
(40)
(41)
(39)
(39)
(39)
(40)
(41)
(44)
(47)
(48)
(51)
(52)
(53)
(55)
(56)
(56)
(59)
(61)
(63)
(66)
(68)
(69)
(70)
(69)
(69)
(68)
(69)
(71)
(74)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
Other Operating Expenses
2
3
2
(0)
(1)
(1)
(1)
0
(1)
(1)
(1)
(0)
(2)
(1)
(1)
(0)
(1)
(1)
(4)
(0)
(4)
(3)
(1)
(0)
(0)
(1)
(0)
1
0
0
4
0
3
3
0
2
2
3
2
0
0
3
3
5
6
3
3
0
0
0
(1)
(1)
(1)
(0)
(46)
(49)
(51)
(53)
(5)
1
1
2
12
9
10
12
5
8
11
14
8
4
4
2
5
(1)
(4)
(4)
(5)
(6)
(1)
(2)
(6)
(6)
(10)
(10)
(7)
(2)
(4)
(4)
(5)
(6)
(7)
(9)
(10)
(10)
Operating Income
44
N/A
43
-3%
41
-4%
50
+23%
36
-28%
41
+13%
54
+33%
63
+16%
64
+2%
65
+2%
55
-16%
52
-6%
56
+8%
59
+5%
62
+5%
73
+18%
80
+10%
95
+18%
101
+6%
106
+5%
113
+7%
115
+2%
118
+3%
113
-4%
121
+7%
124
+2%
122
-2%
125
+3%
109
-13%
100
-8%
106
+6%
106
+0%
117
+10%
119
+2%
117
-2%
108
-8%
109
+0%
109
0%
112
+4%
119
+6%
130
+9%
138
+6%
139
+1%
142
+2%
144
+2%
147
+2%
158
+8%
162
+2%
159
-2%
171
+8%
175
+2%
181
+4%
188
+4%
172
-8%
128
-26%
129
+0%
136
+6%
157
+15%
214
+36%
226
+6%
232
+3%
226
-3%
236
+5%
240
+2%
235
-2%
244
+4%
243
0%
251
+3%
265
+6%
285
+7%
292
+2%
298
+2%
314
+6%
340
+8%
376
+10%
418
+11%
510
+22%
612
+20%
689
+13%
757
+10%
769
+2%
785
+2%
786
+0%
755
-4%
733
-3%
694
-5%
692
0%
705
+2%
662
-6%
604
-9%
586
-3%
590
+1%
587
0%
616
+5%
625
+1%
631
+1%
Pre-Tax Income
Interest Income Expense
(11)
(11)
(10)
(7)
(9)
(8)
(8)
(7)
(8)
(8)
(7)
(7)
(7)
(8)
(10)
(13)
(13)
(13)
(12)
(11)
(10)
(8)
(8)
(9)
(10)
(12)
(14)
(16)
(15)
(15)
(14)
(15)
(16)
(17)
(18)
(18)
(18)
(18)
(18)
(18)
(17)
(17)
(17)
(16)
(18)
(16)
(16)
(15)
(15)
(16)
(14)
(12)
(11)
(9)
(13)
(13)
(11)
(10)
(9)
(7)
(7)
(7)
(6)
(7)
(6)
(6)
(6)
(6)
(6)
(6)
(6)
(0)
0
2
0
(5)
(9)
(8)
(7)
(6)
(5)
(6)
(3)
3
5
6
10
8
11
10
5
6
6
7
9
9
Non-Reccuring Items
(3)
2
(9)
(11)
(15)
(19)
(11)
9
15
19
20
(3)
(1)
1
1
1
(5)
(7)
(6)
(10)
0
0
(10)
(17)
(28)
(22)
(15)
1
(2)
(7)
(5)
(8)
(10)
(10)
(9)
(16)
(17)
(20)
(23)
(8)
(7)
(19)
(19)
(17)
(17)
(2)
(1)
0
0
0
0
0
0
0
0
0
(26)
(24)
(26)
(29)
(4)
(16)
(14)
(11)
(14)
(6)
(8)
(10)
(8)
(7)
(7)
(6)
(5)
(10)
(13)
(12)
(14)
(9)
(4)
(8)
(7)
(5)
(54)
(79)
(88)
(92)
(46)
(15)
(8)
(5)
(0)
(9)
(22)
(24)
(29)
(38)
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
5
7
6
5
1
(0)
(1)
(1)
0
1
3
4
5
6
5
4
3
1
0
0
4
(1)
4
3
(2)
(1)
(1)
(1)
(1)
(1)
Pre-Tax Income
30
N/A
34
+12%
22
-35%
32
+47%
12
-63%
14
+15%
35
+156%
65
+84%
72
+11%
77
+7%
68
-12%
42
-37%
48
+13%
51
+6%
52
+3%
61
+17%
63
+2%
75
+20%
82
+10%
85
+3%
103
+21%
106
+4%
100
-6%
86
-14%
84
-3%
90
+7%
93
+3%
110
+18%
92
-16%
78
-15%
87
+11%
83
-4%
91
+9%
92
+2%
91
-1%
75
-18%
74
-1%
71
-4%
71
+1%
93
+30%
106
+15%
103
-3%
103
+0%
109
+5%
110
+1%
129
+17%
142
+10%
147
+4%
144
-2%
155
+8%
161
+4%
169
+5%
177
+5%
163
-8%
115
-29%
116
+1%
100
-14%
123
+23%
179
+45%
190
+6%
222
+17%
203
-8%
216
+7%
222
+3%
217
-3%
236
+9%
234
-1%
241
+3%
257
+7%
276
+8%
280
+1%
292
+4%
308
+6%
331
+7%
364
+10%
401
+10%
490
+22%
599
+22%
682
+14%
749
+10%
762
+2%
778
+2%
733
-6%
680
-7%
650
-4%
608
-7%
659
+8%
698
+6%
668
-4%
611
-8%
589
-4%
586
-1%
569
-3%
597
+5%
604
+1%
601
-1%
Net Income
Tax Provision
(10)
(11)
(6)
(9)
(2)
(2)
(11)
(23)
(26)
(27)
(24)
(12)
(13)
(14)
(14)
(18)
(17)
(21)
(23)
(25)
(31)
(28)
(23)
(17)
(14)
(18)
(20)
(24)
(18)
(13)
(18)
(14)
(17)
(18)
(16)
(14)
(14)
(12)
(14)
(24)
(27)
(28)
(31)
(33)
(31)
(35)
(37)
(40)
(41)
(45)
(46)
(47)
(50)
(45)
(27)
(26)
(21)
(29)
(50)
(54)
(50)
(36)
(35)
1
(9)
(12)
(6)
(44)
(48)
(57)
(60)
(59)
(58)
(58)
(69)
(73)
(86)
(104)
(95)
(109)
(101)
(112)
(117)
(120)
(116)
(107)
(119)
(122)
(115)
(102)
(105)
(108)
(115)
(124)
(125)
(122)
Income from Continuing Operations
20
23
16
23
10
11
24
41
46
49
44
31
35
37
38
44
45
54
59
60
72
78
78
69
70
72
73
86
74
65
69
70
73
74
75
61
60
58
57
69
79
74
72
76
78
93
105
107
102
110
115
122
128
118
88
90
79
95
130
135
172
167
181
223
208
224
228
197
209
219
220
233
251
272
295
329
404
495
587
640
661
666
616
560
534
501
539
576
552
509
484
478
453
473
479
479
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Equity Earnings Affiliates
0
0
(0)
(0)
0
1
2
2
2
2
3
3
3
3
2
2
2
2
1
2
2
2
3
3
2
2
2
1
1
1
2
3
4
5
5
4
5
5
6
6
6
6
6
5
5
4
5
5
5
5
5
5
5
5
5
6
6
7
8
8
11
9
9
9
8
9
9
8
7
7
7
9
10
13
17
17
20
23
24
20
22
19
18
21
19
19
18
18
16
16
16
15
14
14
13
14
Net Income (Common)
(5)
N/A
(2)
+49%
(5)
-100%
18
N/A
16
-13%
18
+10%
18
+3%
32
+75%
35
+10%
36
+2%
36
+1%
20
-44%
26
+29%
31
+20%
35
+11%
46
+34%
51
+10%
59
+15%
65
+9%
67
+4%
76
+13%
81
+7%
80
-1%
71
-11%
71
0%
73
+4%
74
+2%
86
+16%
75
-13%
66
-12%
70
+6%
73
+4%
77
+6%
79
+3%
80
+1%
65
-18%
65
0%
64
-2%
63
-1%
76
+21%
85
+13%
81
-5%
79
-3%
81
+3%
83
+3%
98
+18%
110
+12%
112
+2%
108
-4%
115
+7%
119
+4%
127
+7%
133
+5%
123
-7%
94
-24%
96
+2%
85
-11%
102
+20%
138
+35%
144
+4%
182
+27%
176
-3%
190
+8%
151
-21%
133
-11%
151
+13%
155
+3%
207
+34%
219
+6%
229
+5%
230
+0%
242
+5%
261
+8%
286
+10%
312
+9%
346
+11%
423
+22%
519
+23%
613
+18%
662
+8%
684
+3%
686
+0%
631
-8%
586
-7%
552
-6%
519
-6%
559
+8%
593
+6%
569
-4%
525
-8%
500
-5%
493
-1%
467
-5%
488
+4%
492
+1%
494
+0%
EPS (Diluted)
-0.07
N/A
-0.03
+57%
-0.07
-133%
0.31
N/A
0.27
-13%
0.3
+11%
0.33
+10%
0.54
+64%
0.58
+7%
0.58
N/A
0.57
-2%
0.32
-44%
0.4
+25%
0.47
+17%
0.52
+11%
0.71
+37%
0.77
+8%
0.85
+10%
0.98
+15%
0.99
+1%
1.1
+11%
1.08
-2%
1.08
N/A
0.97
-10%
0.97
N/A
1
+3%
1.02
+2%
1.19
+17%
1.04
-13%
0.92
-12%
0.97
+5%
1
+3%
1.05
+5%
1.07
+2%
1.08
+1%
0.88
-19%
0.88
N/A
0.85
-3%
0.84
-1%
1.02
+21%
1.14
+12%
1.1
-4%
1.13
+3%
1.12
-1%
1.18
+5%
1.39
+18%
1.53
+10%
1.57
+3%
1.48
-6%
1.6
+8%
1.65
+3%
1.75
+6%
1.83
+5%
1.69
-8%
1.28
-24%
1.3
+2%
1.15
-12%
1.37
+19%
1.85
+35%
1.91
+3%
2.43
+27%
2.34
-4%
2.51
+7%
1.98
-21%
1.76
-11%
2
+14%
2.04
+2%
2.74
+34%
2.9
+6%
3.04
+5%
3.04
N/A
3.21
+6%
3.45
+7%
3.78
+10%
4.12
+9%
4.57
+11%
5.58
+22%
6.85
+23%
8.05
+18%
8.66
+8%
9
+4%
9.04
+0%
8.32
-8%
7.72
-7%
7.31
-5%
6.88
-6%
7.42
+8%
7.88
+6%
7.65
-3%
7.12
-7%
6.8
-4%
6.69
-2%
6.4
-4%
6.72
+5%
6.77
+1%
6.79
+0%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett